Abstract:Objective The purpose of this study is to investigate the molecular basis of ionic remodeling in patients with atrial fibrillation (AF). Methods The mRNA expression of L-type voltage dependent calcium channel α1c subunit (LVDCC α1c)? voltage dependent KV4.3 potassium channel α subunit (VDKV4.3 α) and voltage dependent sodium channel α subunit (VDSC α) were detected by semi-quantitative RT-PCR in patients with paroxysmal atrial fibrillation (PAF), in patients with chronic AF for less than 6 months (AF6 M) and more than 6 months (AF6 M). Subjects with persisting sinus rhythm (SR) were considered as control group, they all had underlying rheumatic heart disease (RHD) or congenital heart disease (CHD). Semi-quantitative analysis of gene express of above mentioned each channel subunit was performed by imagemaster VDS-CL. Results There were no significant difference in the gene expression of LVDCC α1c? VDSC α and VDKV4.3 α between RHD and CHD patients in SR group; gene expression of VDSC α remained unchanged in all groups. The expression of LVDCC α1c was significantly decreased in patients with AF6 M and remained stable in patients with PAF and AF6 M. The expression of VDKV4.3 α was reduced significantly in patients with PAF, AF6 M and AF6 M, as compared with that in patients with sinus rhythm. A significant correlation was found between the mRNA expression of LVDCC α and AF score, mean atrial rate, left and right atrial diameter. One-way ANOVA showed that mRNA expression of LVDCC α1c in AF6 M was still low after correcting the effect of atrial diameter ( P 0.01). There was a similar significant correlation between mRNA expression of VDKV4.3 α and AF score, left atrial diameter and mean atrial rate. The mRNA expression of KV4.3 α was decreased significantly after the effect of atrial diameter corrected by one-way ANOVA ( P 0.05). Conclusion These data suggest that transcriptional down-regulation of L-type calcium channel and KV4.3 potassium channel may serve as the molecular basis of I CaL and I tol remodeling respectively in patients with chronic AF. The mRNA expression of LVDCC α1c remains unchanged in patients with PAF and AF6 M, whose I CaL remodeling may be associated with post-transcriptional abnormality and/or activation of proteolytic system. The mRNA expression of VDSC α, in accordance with I Na , keep stable in patients with AF.

Cx43 is involved in electrical remodeling of atrial myocytes through regu-lating L-type calcium current

Connexin 43 participates in atrial electrical remodelling through colocalization with calcium channels in atrial myocytes

[Expression of Connexin in Atrium of Patients with Atrial Fibrillation and Its Signal Transduction Pathway].

Changes of Protein Expression of Connexin 40, 43 in Human Atrial Fibrillation

THE EXPRESSION OF CONNEXIN 43 IN HUMAN CARDIAC CONDUCTION SYSTEM

Gap junction and Na+-H+ exchanger alternations in fibrillating and failing atrium.

Connexin 43 is involved in the sympathetic atrial fibrillation in canine and canine atrial myocytes.

Decreased connexin 43 and increased fibrosis in atrial regions susceptible to complex fractionated atrial electrograms.

Involvement of ERK1/2 in Cx43 depression induced by macrophage migration inhibitory factor in atrial myocytes.

Cross-talk Between Macrophages and Atrial Myocytes in Atrial Fibrillation

E0356 the Research on Calcium Homeostasis Expression and Gene Transcription of Atrial Myocytes in Patients with Atrial Fibrillation

Regulation of cardiac CACNB2 by microRNA-499: Potential role in atrial fibrillation.

Cold-inducible RNA-binding Protein Modulates Atrial Fibrillation Onset by Targeting Multiple Ion Channels.

Cx43 overexpression reduce the incidence of obstructive sleep apnea associated atrial fibrillation via the CaMKⅡγ/HIF-1 axis

Oxidized Low-Density Lipoprotein (Ox-Ldl) Cholesterol Induces the Expression of Mirna-223 and L-Type Calcium Channel Protein in Atrial Fibrillation

Effects of Atrial Fibrillation on Expressions of Connexin40 and Connexin43 in Atrial Myocytes in Rheumatic Heart Disease Patients

Inhibiting microRNA-155 attenuates atrial fibrillation by targeting CACNA1C

Molecular Basis of Ionic Remodeling in Patients with Atrial Fibrillation

Connexin 43, a new therapeutic target for cardiovascular diseases

Remodeling of L-type Calcium Current of Atrial Myocytes During the Development of Human Atrial Fibrillation

Gene Expression of Atrial Connexin40 and Connexin43 in Human Atrial Fibrillation